Your browser doesn't support javascript.
loading
Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet's signaling cascades as new outcome measures in clinical trials.
Pellerin, David; Çaku, Artuela; Fradet, Mathieu; Bouvier, Paméla; Dubé, Jean; Corbin, François.
Affiliation
  • Pellerin D; a Department of Biochemistry, Faculty of Medicine and Health Sciences , Université de Sherbrooke , Sherbrooke , QC , Canada.
  • Çaku A; a Department of Biochemistry, Faculty of Medicine and Health Sciences , Université de Sherbrooke , Sherbrooke , QC , Canada.
  • Fradet M; a Department of Biochemistry, Faculty of Medicine and Health Sciences , Université de Sherbrooke , Sherbrooke , QC , Canada.
  • Bouvier P; a Department of Biochemistry, Faculty of Medicine and Health Sciences , Université de Sherbrooke , Sherbrooke , QC , Canada.
  • Dubé J; a Department of Biochemistry, Faculty of Medicine and Health Sciences , Université de Sherbrooke , Sherbrooke , QC , Canada.
  • Corbin F; a Department of Biochemistry, Faculty of Medicine and Health Sciences , Université de Sherbrooke , Sherbrooke , QC , Canada.
Biomarkers ; 21(6): 497-508, 2016 Sep.
Article in En | MEDLINE | ID: mdl-27058300

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Lovastatin / MAP Kinase Signaling System / Fragile X Syndrome / Anticholesteremic Agents Limits: Female / Humans / Male Language: En Journal: Biomarkers Journal subject: BIOQUIMICA Year: 2016 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Platelets / Lovastatin / MAP Kinase Signaling System / Fragile X Syndrome / Anticholesteremic Agents Limits: Female / Humans / Male Language: En Journal: Biomarkers Journal subject: BIOQUIMICA Year: 2016 Document type: Article Affiliation country: Country of publication: